Gene Patents: DoJ Offers Compromise Giving Deference To Human-Engineered DNA
Executive Summary
The Department of Justice is advocating a compromise position in litigation over whether genes should be patented: it is making a distinction between DNA isolated from the body and human-engineered DNA molecules.